Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
US9840491B2 · kind B2 · utility
21Cited by
60References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2016 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Feb 4, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula:where R1, R2, R3, R4, R4′, X1, Y1, Y2, Y3, Y4, n, and m are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.